Cagrilintide combined with semaglutide (CagriSema) for treatment of type 2 diabetes In a recent small phase 2 trial (n=92), 3 groups of patients with type 2 diabetes were randomized to receive cagrilintide co-administered with semaglutide (the authors called this combination CagriSema), cagrilintide or semaglutide, both in doses escalated to 2.4 mg once weekly (table 1) [10]
MachinDRTrottDWGogulamudiVRIslamMTBloomSIVinkHet al
Ultimately, further research is essential to establish a clearer understanding of how Wegovy may impact yeast infection susceptibility among its users
Radford-Smith DE, Oke K, Costa CFFA, Anthony DC (2025) Systematic review and meta-analysis of microbiota-gut-astrocyte axis perturbation in neurodegeneration, brain injury, and mood disorders
Chronic Kidney Disease Chronic kidney disease, frequently brought on by longstanding diabetes, can advance to major kidney events, such as end stage renal disease, the need for dialysis, and transplantation each of which can have significant impacts on health and mortality
Make lifestyle changes